BACK

Head and Neck Trials

Clinical trial information


Select trial for more information

Area under investigation=true,HNSCC

eVOLVE-02 trial overview

Tumor

Advanced or metastatic tumors (Cervical, HNSCC, pleural mesothelioma, and ESCC)

Trial Identifier

NCT06535607

Phase

II

Regimen

Volrustomig monotherapy; volrustomig + chemotherapy

Visit ct.gov
Go

eVOLVE-HNSCC trial overview

Tumor

Unresected locally advanced HNSCC not progressed on definitive concurrent chemoradiotherapy

Trial Identifier

NCT06129864

Phase

III

Regimen

Volrustomig; observational arm

Visit ct.gov
Go

Some compounds herein refer to selected AstraZeneca pipeline products still under development. AstraZeneca pipeline products are investigational products and, as such, are not approved by the US Food & Drug Administration (FDA), the European Medicines Agency (EMA) or any other regulatory agency for the uses under investigation. Information regarding these investigational products should, under no circumstances, be regarded as a recommendation for their use or of their safety or efficacy.

This site is intended for US Healthcare Professionals.

Veeva ID: Z4-84958 US-109129 DE-92568 Last Updated October 20263/26
©2026 AstraZeneca. All rights reserved.